share_log

Recap: Journey Medical Q4 Earnings

Benzinga ·  Mar 22 05:05

Journey Medical (NASDAQ:DERM) reported its Q4 earnings results on Thursday, March 21, 2024 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Journey Medical beat estimated earnings by 138.0%, reporting an EPS of $0.03 versus an estimate of $-0.08.

Revenue was down $709 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $1.14 which was followed by a 10.0% increase in the share price the next day.

Here's a look at Journey Medical's past performance:

QuarterQ3 2023Q2 2023Q1 2023Q4 2022
EPS Estimate-0.15-0.33-0.45-0.47
EPS Actual0.99-0.04-0.30-0.17
Revenue Estimate16.88M14.81M16.18M16.58M
Revenue Actual34.54M17.17M12.21M15.97M

To track all earnings releases for Journey Medical visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment